Login to Your Account



NovaBay in $50M Skin Drug Deal with Galderma

By Donna Young


Thursday, March 26, 2009
Shares of NovaBay Pharmaceuticals Inc. rose 8.3 percent Wednesday after the Emeryville, Calif.-based firm said it inked a deal with Swiss firm Galderma SA to develop and commercialize antimicrobial compounds to treat acne and impetigo and other potential indications. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription